Download Files:
Carteolol-d9 (hydrochloride)
SKU
HY-17495AS-1 mg
Category Isotope-Labeled Compounds
Tags Adrenergic Receptor;Isotope-Labeled Compounds, Cardiovascular Disease; Endocrinology, GPCR/G Protein;Neuronal Signaling;Others
$548
Only 1000 item(s) left in stock.
Products Details
Product Description
– Carteolol-d9 (hydrochloride) is the deuterium labeled Carteolol hydrochloride. Carteolol hydrochloride (OPC-1085 hydrochloride) is a non-selective beta blocker used to treat glaucoma[1][2].
Web ID
– HY-17495AS
Shipping
– Room temperature
Molecular Formula
– C16H16D9ClN2O3
References
– [1]Russak EM, et al. Impact of Deuterium Substitution on the Pharmacokinetics of Pharmaceuticals. Ann Pharmacother. 2019;53(2):211-216. |[2]Kuwahara, K., et al., Carteolol hydrochloride protects human corneal epithelial cells from UVB-induced damage in vitro. Cornea, 2005. 24(2): p. 213-20.|[3]Trinquand, C., et al., [Efficacy and safety of long-acting carteolol 1% once daily. A double-masked, randomized study]. J Fr Ophtalmol, 2003. 26(2): p. 131-6.
CAS Number
– 1346602-13-8
Molecular Weight
– 337.89
SMILES
– [2H]C([2H])([2H])C(C([2H])([2H])[2H])(C([2H])([2H])[2H])NCC(O)COC1=C2C(NC(CC2)=O)=CC=C1.Cl[H]
Clinical Information
– No Development Reported
Research Area
– Cardiovascular Disease; Endocrinology
Solubility
– 10 mM in DMSO
Target
– Adrenergic Receptor;Isotope-Labeled Compounds
Pathway
– GPCR/G Protein;Neuronal Signaling;Others
Product type
– Isotope-Labeled Compounds
Disclaimer: All products are for Research use only unless clearly stated otherwise on the product datasheet. Datasheets provided on the website are drafts for reference purpose only and you are requested to always refer to the hard copy included in the kit for your experimentation. Agdia Products are available for delivery only in Canada.